Skip to main content

Spesolimab Side Effects

Medically reviewed by Drugs.com. Last updated on Dec 17, 2023.

Applies to spesolimab: intravenous solution.

Serious side effects of Spesolimab

Along with its needed effects, spesolimab may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking spesolimab:

More common

Less common

Incidence not known

Other side effects of Spesolimab

Some side effects of spesolimab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

Less common

For Healthcare Professionals

Applies to spesolimab: intravenous solution, subcutaneous solution.

Dermatologic

Common (1% to 10%): Cellulitis, furuncle, herpes dermatitis, pruritus and prurigo, subcutaneous abscess, urticaria[Ref]

Two patients experienced drug reaction with eosinophilia and systemic symptoms (DRESS). The validation scoring for reported cases were "no DRESS" and "possible DRESS".[Ref]

Gastrointestinal

Very common (10% or more): Diarrhea (11%)

Common (1% to 10%): Gastritis, nausea and vomiting, oral herpes[Ref]

General

The most common adverse effects were infections. Infection occurred in 14% of patients during the first week of treatment as compared to 6% in the placebo group. The majority of infections reported were mild (29%) to moderate (71%).[Ref]

Genitourinary

Common (1% to 10%): Bacteriuria, urinary tract infection, vulvovaginal candidiasis, vulvovaginal mycotic infection[Ref]

Local

Common (1% to 10%): Infusion site hematoma and bruising

Not reported: Injection site reactions[Ref]

During clinical trials, injection site reactions (including injection site erythema, injection site swelling, injection site pain, injection site induration, and injection site warmth) were observed.[Ref]

Nervous system

Common (1% to 10%): Headache

Uncommon (0.1% to 1%): Guillain-Barre syndrome[Ref]

Ocular

Common (1% to 10%): Eye edema[Ref]

Other

Common (1% to 10%): Asthenia and fatigue, bacteremia, device-related infection, otitis externa[Ref]

Respiratory

Common (1% to 10%): Dyspnea, influenza, latent tuberculosis, upper respiratory tract infection[Ref]

References

1. Product Information. Spevigo (spesolimab). Boehringer Ingelheim. 2022;1.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.